Original Source(s)
Related Content
Effects of the active parts of Yangxin Tongmai Formula on myocardial injury and spatial metabolic remodeling in rats with myocardial ischemia-reperfusion injury
by Di Ye, Yi Wang, Ziyuan Zhao, Caiyue Lin, Wenhua Xu, Jinghui Zheng
July 20, 2026
FDA Cites Manufacturing Issues for Cytisinicline
Application supported by Phase 3 smoking-cessation data and long-term safety findings.
June 22, 2026
-
3 min